Spyre Therapeutics (SYRE) Net Equity Issued and Repurchased (2015 - 2026)
Spyre Therapeutics' Net Equity Issued and Repurchased came in at $432.56 million for Q2 2026, compared with $731,000 a year earlier.
Powered by 
Analysis
Spyre Therapeutics (SYRE) Net Equity Issued and Repurchased (2015 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Spyre Therapeutics reported Net Equity Issued and Repurchased of $437.6 million; for FY2025, it came in at $3.31 million, down 56.0% from FY2024.
- Net Equity Issued and Repurchased carries a five-year compound annual growth rate of 32.3% (FY2020 to FY2025).
- Going back by year, Net Equity Issued and Repurchased was $7.51 million in FY2024, $405,000 in FY2023 (+82.4%), $222,000 in FY2022 (-88.3%) and $1.9 million in FY2021 (+133.2%).
- The Q2 2026 figure represents the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2015.
- Business Quant data shows SYRE's Net Equity Issued and Repurchased at $2.68 million (Q1 2026), $1.75 million (Q4 2025) and $608,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | - |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 43.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 6.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 9.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Spyre Therapeutics | 8.21 Bn | 8.21 Bn | - | 432.56 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 432.56 Mn |
| Mar 31, 2026 | 2.68 Mn |
| Dec 31, 2025 | 1.75 Mn |
| Sep 30, 2025 | 608,000.00 |
| Jun 30, 2025 | 731,000.00 |
| Mar 31, 2025 | 218,000.00 |
| Dec 31, 2024 | -161.34 Mn |
| Sep 30, 2024 | -220,000.00 |
| Jun 30, 2024 | -135,000.00 |
| Mar 31, 2024 | 169.21 Mn |
| Dec 31, 2023 | 282,000.00 |
| Sep 30, 2023 | 105,000.00 |
| Mar 31, 2023 | 18,000.00 |
| Sep 30, 2022 | 38,000.00 |
| Mar 31, 2022 | 184,000.00 |
| Dec 31, 2021 | 249,000.00 |
| Sep 30, 2021 | 1.25 Mn |
| Jun 30, 2021 | 36,000.00 |
| Mar 31, 2021 | 367,000.00 |
| Dec 31, 2020 | 72,000.00 |
API Access
Spyre Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SYRE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "SYRE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=SYRE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();